Teva's market cap is currently 110.84B. The company's EPS TTM is 254.1; its P/E ratio is 46.49; Teva is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is 211.10. See an overview of income statement, balance sheet, and cash flow financials.
